Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proto Labs IncPRLB · Entity 4553 | Director | May 18, 2021 | May 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proto Labs Inc
Report date May 18, 2021 · Filed May 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,106 |
Reported balance
After 2021-05-18 transaction · row 1
1 source rowRow 1 · 2021-05-18 · Grant · Acquired 1,520 · Balance 14,106 F1: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2021 Filed May 20, 2021 20:57 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012946 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,106 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:53 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,000 | $151.19 | $151,185.00 |
DisclosureSEC source: 0001437749-21-004882 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,586 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:33 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,000 | $132.75 | $132,746.40 |
DisclosureSEC source: 0001437749-20-018753 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,586 F1 · price: Reflects the weighted average price of 1,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 24, 2020 with sale prices ranging from $132.72 to $132.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:53 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011579 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,586 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:39 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010409 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,389 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 536 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 536 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · derivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,113 | $162.95 | $181,364.91 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 1,113 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 14, 2018 with sale prices ranging from $162.95 to $163.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 536 | $70.00 | $37,520.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 536 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · derivative · entry 6 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536 Underlying: Common Stock · 536 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 400 | $130.85 | $52,340.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 713 | $131.86 | $94,019.53 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,478 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 713 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 14, 2018 with sale prices ranging from $131.50 to $132.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 536 | $70.00 | $37,520.00 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-012020 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:59 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010373 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F1 · shares: The deferred stock units vest in full on May 16, 2019, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. F2 · balance_after: The reporting person's Form 4 filed on October 5, 2015 inadvertently understated the reporting person's direct holdings by 500 shares. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 537 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072 Underlying: Common Stock · 537 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · derivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,114 | $122.71 | $136,700.05 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 1,114 shares of common stock of Proto Labs, Inc. sold by the reporting person on March 14, 2018 with sale prices ranging from $122.50 to $123.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 537 | $70.00 | $37,590.00 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:19 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-004900 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionStock Option (right to buy) · Derivative | 2,715 | $0.00 Strike: $53.34 | $0.00 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · derivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,715 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 2,715 | $106.79 | $289,941.91 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F1 · price: Reflects the weighted average price of 2,715 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 12, 2018 with sale prices ranging from $106.50 to $107.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 2,715 | $53.34 | $144,818.10 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:21 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-009859 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F1 · date: This Form 4 supersedes the Form 5 filed on May 22, 2017. F2 · shares: The restricted stock units vest in full on the earlier of 5/18/18 or the date of the Company's 2018 annual meeting of shareholders. Read SEC document |
| May 18, 2017 Filed May 22, 2017 22:20 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 1,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-009840 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F1 · shares: The restricted stock units vest in full on the earlier of 5/18/18 or the date of the Company's 2018 annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.